Substance P drives fear extinction in a specific brain region (lateral interpeduncular nucleus) by enhancing glutamate signaling through an endocannabinoid-mediated mechanism, while simultaneously released glycine opposes this plasticity.
NK1R required for fear extinction but not fear conditioningSubstance P signaling through its receptor (NK1R) in the interpeduncular nucleus selectively promotes the unlearning of fear without affecting the initial fear memory — a dissociation with clear therapeutic implications
What the researchers found
Activation of substance P-positive neurons in the dorsomedial habenula causes simultaneous release of glutamate, glycine, and substance P in the lateral interpeduncular nucleus (LIPN). These co-released signals have opposing effects on synaptic plasticity: glycine receptor activity inhibits long-lasting potentiation of glutamatergic synapses, while substance P enhances it.
Substance P achieves this potentiation through a specific cascade: it triggers endocannabinoid CB1 receptor-mediated suppression of GABAB receptor activity, which disinhibits the system and allows substance P to produce a long-lasting increase in glutamate release. Behaviorally, NK1R (the substance P receptor) in the IPN was specifically required for fear extinction but not for the initial fear conditioning, demonstrating a selective role in fear unlearning.
Why it matters
Fear extinction is the central mechanism behind exposure therapy for anxiety disorders and PTSD — the most effective behavioral treatment for these conditions. Understanding the molecular mechanisms that enable fear extinction could lead to drugs that enhance therapy outcomes. The discovery that substance P in a specific brain circuit selectively promotes fear extinction (without affecting fear learning) makes the NK1 receptor a potential therapeutic target for anxiety disorders, with the precision to enhance fear unlearning without disrupting other memory processes.
How the study worked
The study used electrophysiological recordings in mouse brain slices to measure synaptic plasticity in LIPN neurons. Optogenetic activation was used to stimulate specific substance P-positive dMHb neurons. Pharmacological tools targeted glycine receptors, NK1 receptors (substance P receptor), CB1 endocannabinoid receptors, and GABAB receptors to dissect the signaling cascade. Behavioral experiments used fear conditioning and extinction paradigms with NK1R manipulations in the IPN.
What this study cannot tell us
The study was conducted in mice, and direct translation to human brain circuitry requires caution. Electrophysiological recordings were performed in brain slices, which lack the full connectivity of intact circuits. The behavioral experiments targeted the NK1R specifically in the IPN, but substance P acts in many brain regions, so systemic NK1R manipulation may have different effects. The specific role of glycine co-release in fear behaviors was not directly tested behaviorally. Sample sizes for electrophysiology experiments were not detailed in the abstract.
How to read the evidence
This is a preclinical mechanistic study combining electrophysiology, optogenetics, pharmacology, and behavioral assays in mice. Published in Neuropsychopharmacology, the work is methodologically rigorous with convergent evidence from multiple approaches, but findings are limited to the mouse model.
When this study was published
Published in 2019, this study reflects relatively recent work on the habenula-interpeduncular pathway's role in fear regulation — a research area that has continued to grow in importance.
The bigger picture
This study connects three major neuroscience topics: neuropeptide co-transmission (how neurons release multiple signaling molecules simultaneously), the habenula-interpeduncular pathway (increasingly recognized in mood and fear regulation), and the endocannabinoid system (known for its role in fear extinction). The finding that substance P promotes fear extinction through endocannabinoid signaling is particularly notable because both the NK1 receptor and the endocannabinoid system have been targets of drug development for anxiety and PTSD, and this study reveals how they interact in a specific circuit.
Questions still open
- Could NK1R agonists administered to the IPN or systemically enhance exposure therapy outcomes in PTSD patients?
- Does the glycine-substance P balance in this circuit shift in anxiety disorders, potentially explaining impaired fear extinction?
- How does the endocannabinoid component of this mechanism relate to reports that cannabis can both enhance and impair fear extinction?
Common questions
What is fear extinction and why does it matter for treating PTSD?
How do substance P and glycine compete in the brain?
Read the original research
Opposing effects of an atypical glycinergic and substance P transmission on interpeduncular nucleus plasticity.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 44(10), 1828-1836
Citation
Melani, Riccardo; Von Itter, Richard; Jing, Deqiang; Koppensteiner, Peter; Ninan, Ipe. (2019). Opposing effects of an atypical glycinergic and substance P transmission on interpeduncular nucleus plasticity.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 44(10), 1828-1836. https://doi.org/10.1038/s41386-019-0396-6